PT801561E - Composicao e metodos para a entrega transdermica de drogas labeis a acido - Google Patents

Composicao e metodos para a entrega transdermica de drogas labeis a acido

Info

Publication number
PT801561E
PT801561E PT96902047T PT96902047T PT801561E PT 801561 E PT801561 E PT 801561E PT 96902047 T PT96902047 T PT 96902047T PT 96902047 T PT96902047 T PT 96902047T PT 801561 E PT801561 E PT 801561E
Authority
PT
Portugal
Prior art keywords
transdermic
drugs
labor
delivery
acid
Prior art date
Application number
PT96902047T
Other languages
English (en)
Inventor
Li Chensheng
Original Assignee
Noven Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noven Pharma filed Critical Noven Pharma
Publication of PT801561E publication Critical patent/PT801561E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT96902047T 1995-01-06 1996-01-11 Composicao e metodos para a entrega transdermica de drogas labeis a acido PT801561E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36975695A 1995-01-06 1995-01-06

Publications (1)

Publication Number Publication Date
PT801561E true PT801561E (pt) 2005-07-29

Family

ID=23456790

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96902047T PT801561E (pt) 1995-01-06 1996-01-11 Composicao e metodos para a entrega transdermica de drogas labeis a acido

Country Status (16)

Country Link
EP (1) EP0801561B1 (pt)
JP (1) JP4081139B2 (pt)
KR (1) KR100543351B1 (pt)
AR (1) AR002701A1 (pt)
AT (1) ATE292457T1 (pt)
AU (1) AU718530B2 (pt)
CA (1) CA2209669C (pt)
DE (1) DE69634559T2 (pt)
DK (1) DK0801561T3 (pt)
ES (1) ES2239767T3 (pt)
IL (1) IL116539A (pt)
NZ (1) NZ301153A (pt)
PT (1) PT801561E (pt)
TW (1) TW438598B (pt)
WO (1) WO1996020699A1 (pt)
ZA (1) ZA9670B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780050A (en) * 1995-07-20 1998-07-14 Theratech, Inc. Drug delivery compositions for improved stability of steroids
EP1021204B1 (en) * 1997-09-26 2005-12-28 Noven Pharmaceuticals, Inc. Bioadhesive compositions and methods for topical administration of active agents
DE19906152B4 (de) * 1999-02-10 2005-02-10 Jenapharm Gmbh & Co. Kg Wirkstoffhaltige Laminate für Transdermalsysteme
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
KR20040002890A (ko) * 2001-05-31 2004-01-07 히사미쓰 세이야꾸 가부시키가이샤 경피흡수형 첩부제
DE10220230A1 (de) * 2002-05-06 2003-11-27 Sanol Arznei Schwarz Gmbh Verwendung von Rotigotine zur Behandlung des Restless Leg Syndroms
FR2905601A1 (fr) * 2006-09-11 2008-03-14 Innoderm Sarl Utilisation de derives oleiques comme methode et composition favorisant la penetration cutanee des actifs contenus dans les compositions cosmetiques, pharmaceutiques ou dermatologiques.
HU227970B1 (en) 2007-07-10 2012-07-30 Egis Gyogyszergyar Nyrt Pharmaceutical compositions containing silicones of high volatility
KR100963162B1 (ko) * 2008-12-15 2010-06-15 김유근 5-아미노레불린산의 안정화 방법
US10213421B2 (en) * 2012-04-04 2019-02-26 Alkahest, Inc. Pharmaceutical formulations comprising CCR3 antagonists
US11154535B2 (en) 2012-07-31 2021-10-26 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
US10045935B2 (en) 2012-07-31 2018-08-14 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
CN109503692A (zh) * 2018-12-05 2019-03-22 华中药业股份有限公司 一种雄甾-17α-甲基-17β-羟基-3-酮的合成方法
WO2020189323A1 (ja) 2019-03-19 2020-09-24 ノーベルファーマ株式会社 薬物の生体への吸収性に優れ、且つ、化学的安定性にも優れる医薬組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE77962T1 (de) * 1985-02-25 1992-07-15 Univ Rutgers Dosierungssystem fuer transdermale absorption von arzneimittelwirkstoffen.
AU601528B2 (en) * 1986-12-22 1990-09-13 Ortho-Mcneil Pharmaceutical, Inc. Resilient transdermal drug-delivery device and compositions and devices employing fatty acid esters/ethers of alkanediols and percutaneous absorption enhancers
CN1021196C (zh) * 1986-12-29 1993-06-16 新泽西州州立大学(鲁杰斯) 透皮雌激素/孕激素药剂单元、系统及方法
US4994267A (en) * 1988-03-04 1991-02-19 Noven Pharmaceuticals, Inc. Transdermal acrylic multipolymer drug delivery system
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
EP0573133A1 (de) * 1988-10-27 1993-12-08 Schering Aktiengesellschaft Mittel zur transdermalen Applikation das Gestoden enthält
US5202125A (en) * 1990-12-10 1993-04-13 Theratech, Inc. Method and systems for administering nitroglycerin transdermally at enhanced transdermal fluxes
DE4210711A1 (de) * 1991-10-31 1993-05-06 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De Transdermale therapeutische systeme mit kristallisationsinhibitoren

Also Published As

Publication number Publication date
JPH10512245A (ja) 1998-11-24
CA2209669C (en) 2007-03-27
AU4650596A (en) 1996-07-24
EP0801561A2 (en) 1997-10-22
TW438598B (en) 2001-06-07
CA2209669A1 (en) 1996-07-11
IL116539A0 (en) 1996-03-31
DK0801561T3 (da) 2005-08-08
NZ301153A (en) 1999-11-29
EP0801561B1 (en) 2005-04-06
KR19980701233A (ko) 1998-05-15
WO1996020699A1 (en) 1996-07-11
DE69634559T2 (de) 2006-02-16
IL116539A (en) 2002-02-10
KR100543351B1 (ko) 2006-04-06
MX9705070A (es) 1998-07-31
AR002701A1 (es) 1998-04-29
ATE292457T1 (de) 2005-04-15
ES2239767T3 (es) 2005-10-01
JP4081139B2 (ja) 2008-04-23
AU718530B2 (en) 2000-04-13
DE69634559D1 (de) 2005-05-12
ZA9670B (en) 1996-07-18

Similar Documents

Publication Publication Date Title
BR9611410A (pt) Método e composição farmacêutica para regular a concentração de lipídios
BR9600821A (pt) Composto formulação farmacêutica e processo para a preparação de um composto
BR9611986A (pt) Compostos processo para a preparação dos mesmos composição farmcéutica e utilização dos compostos
PT0900782E (pt) Ester do acido 2-cianacrilico
BR9609701A (pt) Composição farmacéutica composto e processo para a preparação de compostos
MA23632A1 (fr) Procede de preparation de composes nouveaux et de compostions pharmaceutiques les contenant
PT90120A (pt) Processo para a preparacao de uma composicao farmaceutica contendo deprenil para administracao sistemica transdermica
PT1077692E (pt) Preparacoes farmaceuticas estabilizadas de derivados do acido aminobutirico e processos para a sua preparacao
PT801561E (pt) Composicao e metodos para a entrega transdermica de drogas labeis a acido
BR9601028A (pt) Compostos processo para sua preparação processo para a produção de preparações farmacêuticas preparação farmacêutica medicamento e uso
BR9602150A (pt) Compostos processo para sua preparação processo para a produção de uma formulação farmacêutica formulação farmacêutica e uso
PT956010E (pt) Micro-esferas farmaceuticas de acido valproico para administracao oral
IT9021662A0 (it) Composizioni farmaceutiche per uso topico comprendenti acido iluromicosale sodico e sostanze disinfettanti
BR9607095A (pt) Composto composição farmacêutica e processos para fabricar e para administrar um composto
ITMI931014A0 (it) Composizione farmaceutica a lento rilascio contenente come sostanza attiva un acido biliare
BR9506106A (pt) Composto processo para sua preparação medicamento e composição farmacêutica
BR9408340A (pt) Acido 5-acetamido-2,3,4,5-tetradeoxi-4-guanidino-d-glicero-d-glacto-não-2-enotiranosonico forma critalina processo para a preparação dos mesmos e formulação farmacêutica
ITPD950089A0 (it) Acido ialuronico e suoi derivati esterei per la preparazione di matri-ci per il rilascio controllato di farmaci
PT92188A (pt) Processo para a preparacao de uma solucao aquosa contendo acido cromoglicico e salbutamol
HUP0202088A2 (en) Medicament form for the delivery of collagenase to wounds and process for the preparation thereof
BR9505109A (pt) Compostos processo para sua preparaçao processo para produçao de uma preparaçao farmacêutica tal preparaçao e uso de tais compostos
IT1273471B (it) Derivati dell'acido kojico
FI942581A0 (fi) Menetelmä 5-bromi-6-metoksi-1-naftoehappometyyliesterin valmistamiseksi
BR9603164A (pt) Compostos processo para a preparação dos mesmos processo para a produção de preparações farmacêuticas preparação farmacêutica medicamentos e uso de compostos
IT1295658B1 (it) Composizioni farmaceutiche contenenti acido ricinoleico e loro uso per la terapia antifiammatoria ed analgesica